SOLIGENIX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SOLIGENIX, INC. (SNGX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 6.65 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-31
- SOLIGENIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 6.65K shares, a 1446.98% increase from fiscal 2024.
- SOLIGENIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 430.00 shares, a 59.13% decline from fiscal 2023.
- SOLIGENIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.05K shares, a 73.08% decline from fiscal 2022.
- SOLIGENIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 3.91K shares, a 75.55% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 6.65K shares 10-K · filed 2026-03-31 | ||
| 2024-12-31 | 430.00 shares 10-K · filed 2026-03-31 | ||
| 2023-12-31 | 1.05K shares 10-K · filed 2025-03-21 | 16.93K shares 10-K · filed 2024-03-15 | |
| 2022-12-31 | 3.91K shares 10-K · filed 2024-03-15 | ||
| 2021-12-31 | 15.98K shares 10-K · filed 2023-03-31 | 239.91K shares 10-K · filed 2022-03-29 | |
| 2020-12-31 | 88.22K shares 10-K · filed 2022-03-29 | ||
| 2019-12-31 | 111.86K shares 10-K · filed 2021-03-30 | 107.30K shares 10-K · filed 2020-03-30 | |
| 2012-09-30 | 72.50K shares 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |